Medical Companies

July 15, 2009

Novelos Therapeutics , Inc.

Filed under: Biotechnology — Tags: — medical products @ 12:24 pm

Industry: Pharmaceuticals, Biotechnology
Novelos Therapeutics, Inc. (OTCBB: NVLT) is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of Cancer and Hepatitis. NOV-002, the lead compound currently in Phase 3 development for lung cancer under a SPA and Fast Track, acts together with chemotherapy as a chemoprotectant and an immunomodulator. NOV-002 is also in Phase 2 development for chemotherapy-resistant ovarian cancer and early-stage breast cancer, and is in addition being developed for acute radiation injury. NOV-205 acts as a hepatoprotective agent with immunomodulating and anti-inflammatory properties. NOV-205 is in Phase 1b development for chronic hepatitis C ( www.novelos.com )

Novelos Therapeutics , Inc.
One Gateway Center Suite 504
Newton, Massachusetts 02458
USA

Tel: (617) 244-1616
Fax: (617) 964-6331

  • Caprion Pharmaceuticals Inc.
  • PacifiCare Health Systems Inc.
  • Alacrity Biosciences , Inc.
  • CODA Genomics , Inc.
  • Kendle International Inc.
  • Ciphergen Biosystems , Inc.
  • Genfit
  • Unigen Pharmaceuticals , Inc.
  • Rural Technologies Inc
  • Invitrogen Corporation
  • Brigham and Women’s Hospital
  • Molecular Templates Inc.
  • Hematech , LLC
  • Tissue Repair Company
  • Ride On Center for Kids Inc
  • Neurogen Corporation
  • PEDIATRIC DENTISTRY
  • Napo Pharmaceuticals , Inc.
  • ProteomTech , Inc.
  • Gel Med Sciences , Inc.
  • Medical Companies - Medical Companies Sitemap